ASTH (Astrana Health) Interest Expense: $-59 Mil (TTM As of Mar. 2026)

What is Astrana Health Interest Expense?

Astrana Health ASTH +2.98% 87 Interest Expense is $-59 Mil as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Astrana Health's interest expense for the three months ended in Mar. 2026 was $ -16 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-59 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Astrana Health's Operating Income for the three months ended in Mar. 2026 was $ 29 Mil. Astrana Health's Interest Expense for the three months ended in Mar. 2026 was $ -16 Mil. Astrana Health's Interest Coverage for the quarter that ended in Mar. 2026 was 1.77. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Astrana Health (NAS:ASTH) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Astrana Health's Interest Expense for the three months ended in Mar. 2026 was $-16 Mil. Its Operating Income for the three months ended in Mar. 2026 was $29 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $1,010 Mil.

Astrana Health's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	28.528	/	-16.101
	=	1.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Astrana Health Interest Expense Historical Data

* Premium members only.

The historical data trend for Astrana Health's Interest Expense can be seen below:

Astrana Health Interest Expense Chart

Astrana Health Annual Data

Trend

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-5.39

-7.92

-16.10

-33.10

-49.93

Astrana Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-7.31	-7.38	-17.72	-17.52	-16.10

87GF Score

Astrana Health Inc ASTH

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Astrana Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-59 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-59 Mil mean?

Astrana Health (ASTH) has a Interest Expense of $-59 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Astrana Health and its competitors.

Is Astrana Health's Interest Expense too high?

Astrana Health's current Interest Expense is $-59 Mil. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Astrana Health's Interest Expense compare to MD and SGRY?

Astrana Health's Interest Expense of $-59 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Healthcare Providers & Services company?

A good Interest Expense depends on the Healthcare Providers & Services industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Astrana Health and its competitors. Astrana Health's current Interest Expense is $-59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Astrana Health stock overvalued right now?

Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $43.48 — trading 47.2% below its estimated fair value. The current Interest Expense is $-59 Mil. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Astrana Health (ASTH), the current Interest Expense is $-59 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $43.48 is trading 47.2% below its estimated GF Value™ of $82.34. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

Interest Expense: $-59 Mil
GF Value™: $82.34 vs. price of $43.48 (47.2% below fair value)
GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astrana Health Business Description

Industry Healthcare Healthcare Providers & Services

Comparable Companies MD SGRY ADUS SEM SNDA ACHC AVAH AGL HCSG ARDT HCA XTER:FRE SAU:4013 XKLS:5225 THC BSP:RDOR3 SZSE:300015 DVA NSE:APOLLOHOSP XTER:FME

Other Exchanges 3AM:Germany

Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801

Website https://www.astranahealth.com

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

87GF Score

Get the complete analysis for ASTH

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.48

Price

$82.34

GF Value

View ASTH Analysis

See Interest Expense data for all stocks →